10 COVID-19 vaccine enters third phase clinical test A total of 10 COVID-19 vaccines have entered the third phase clinical test involving attempts against humans. This third phase is most important because it involves volunteers on a larger scale and this phase will also determine the vaccine effective or otherwise. For example, Johnson & Johnson's company who also entered the race to produce COVID-19 vaccines, will use 60,000 volunteers to test their vaccines named Adenovirus 26 or Ad26. The mRNA vaccine produced by German, BioNTech companies in cooperation with Pfizer and Phosun Phrlarma from China used 30,000 volunteers for tests in the United States, Brazil, Germany, and then added 43,000 volunteers. According to the U.S. FDA, one new vaccine produced is considered successful if it can protect 50 % of volunteers from being infected with diseases. Out of these 10 potential vaccines, five have received early or limited approval even though the third phase test has not been obtained. Out of the five vaccines, four companies produced from China and one from Russia. However, experts protest the initial approval given by several countries against vaccines that have not yet passed the third phase. Russian Pesiden, Vladimir V. Putin had to withdraw the announcement he made that Russia had approved the vaccine, Sputnik V. After having protested experts who were concerned with side effects, Putin said, the approval that was announced before depends on the third phase test result. Although it is not known to its effectiveness, several countries have negotiated Russia to get the vaccine between India and Brazil. UAE and China have reportedly given early approval to two vaccines that are still in the third phase test stage. UAE has given early approval to vaccines produced by the Wuhan Institute Biological Product funded by Sinopharm company. The vaccine is only for health officers in UAE. China's military military was reportedly given early approval to get the Ad5 vaccine that gave positive results in the second phase clinical test. Chinese government reportedly gave emergency approval to vaccines known CoronaVac last July for limited use While still in phase three clinical test, the vaccine manufacturer company, Sinovac has sealed the deal to supply the vaccine to Indonesia. Web Source MD, AFP, New York Times
UG Healthcare (Malaysian Glove maker, listed in Singapore), up 17% last 3 days! Biolidic (Test kits), up 30% last 2 days! Healthcare flowing into Singapore market last 3 days! Retailers and Institutions are coming in, funds will flowover to Malaysia soon. Invest healthcare stocks now! Follow the money flow!
Mon 5th Oct EGM for bonus approval. Bonus 2 for 1. Hopefully after bonus approval next week Ruberex will hit another new high with announcement expansion new production line in operation this month.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
SalamSaham
141 posts
Posted by SalamSaham > 2020-09-22 08:43 | Report Abuse
y company keep buying back their share?they know their company worth.